Corporate spending on AI continues to rise, with Nvidia leading the market. Shares of Nvidia are up 47% in the past year, benefitting from increased spending on chips and data centers. Google parent Alphabet plans to invest $175 billion in capital expenditures to support AI demand. Nvidia’s partnership with Thermo Fisher Scientific could revolutionize the healthcare industry by addressing a shortage of healthcare providers. Nvidia’s focus on advanced computing systems positions it as a key player in the life sciences industry, with the potential for significant growth. With an attractive valuation and strong earnings growth expected, Nvidia presents a compelling investment opportunity. Consider joining Stock Advisor for insights on the 10 best stocks to buy now.

Read more at Nasdaq: This Top Artificial Intelligence (AI) Stock Could Have More Upside in 2026